Mealey's (April 27, 2023, 1:41 PM EDT) -- WASHINGTON, D.C. — The Food and Drug Administration lawfully changed the conditions of use for the abortion drug mifepristone by relying on decades of data and published medical literature, the agency says in its April 26 appellant brief filed ahead of a Fifth Circuit U.S. Court of Appeals fast-track hearing on May 17....